SolaranRx, Inc., which is developing a peptide-based technology for treating metastatic melanoma, is among the featured presenters at Biotech Showcase™, January 12-14 in San Francisco. SolaranRx’s lead product, SRX-1177, was recently selected among the 2014 Top 10 Most Interesting Oncology Projects to Watch by Informa and Kantar Health for its strong science and potential to address unmet medical needs in treating metastatic melanoma.
Help employers find you! Check out all the jobs and post your resume.
